Paul Tudor Jones Artivion, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Artivion, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 177,062 shares of AORT stock, worth $5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
177,062
Previous 143,964
22.99%
Holding current value
$5 Million
Previous $3.83 Million
32.96%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$79.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$77.4 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$66.7 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.14B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...